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Abstract 
Background: Tagging proteins is a standard method facilitating protein detection, purification or targeting. When 
tagging a certain protein of interest, it is challenging to predict which tag will give optimal results and will not inter-
fere with protein folding, activity or yields. Ideally, multiple tags and positions are tested which however complicates 
molecular cloning and expression vector generation. In conventional cloning, tags are either added on PCR primers 
(requiring a distinct primer and PCR product per tag) or provided on the vector (typically leaving a restriction site 
scar).
Results: Here we report a vector family of 40 plasmids allowing simple, seamless fusions of a single PCR product 
with various N- and C-terminal tags, signal sequences and promoters. The restriction site free cloning (RSFC) strategy 
presented in this paper relies on seamless cloning using type IIS restriction endonucleases. After cutting out a stuffer 
(placeholder) fragment from the vectors, a single PCR product can be directly inserted in frame into all 40 plasmids 
using blunt end or TA ligations, requiring only verification of the orientation. We have established a RSFC vector fam-
ily for the commonly used protein expression host Pichia pastoris and demonstrated the system with the secretory 
expression of horseradish peroxidase (HRP). HRP fusions to four tags (Myc, FLAG, His, Strep) and two fusion proteins 
(GFP and MBP) showed a 31-fold difference in volumetric activities. C-terminal tagging caused in some cases almost a 
complete loss of function, whereas N-terminal tags showed moderate differences.
Conclusions: The RSFC vectors provide an unprecedented toolbox for expression optimization in P. pastoris. The 
results obtained with HRP underline the importance of comparing different tags to maximize activities of fusion pro-
teins. In a similar fashion the RSFC strategy can be applied in other expression hosts to screen for optimal promoters, 
signal sequences or to facilitate the evaluation of (iso-) enzyme families.
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Background
Protein tags are commonly applied tools facilitating 
purification (affinity tags), enabling immuno-detection 
(epitope tags) or increasing solubility. Fusions to fluo-
rescent proteins help elucidating the cellular localiza-
tion and fusions to signal sequences provide specific 
intracellular targeting or secretion [1, 2]. However, as 
an extrinsic addition to a protein of interest (POI), such 
fusions may also show detrimental effects by affecting 
protein conformation, yields, activity or stability [1, 3]. 
The specific interactions of the POI with a certain tag 
are generally hard to foresee and may also depend on the 
position of the tag (N- or C-terminal). Unknown pro-
teolytic processing or intracellular targeting of the POI 
may also influence the suitability of a specific fusion site. 
In addition, the same tagged protein may behave differ-
ently depending on the host system used (e.g. bacteria, 
Open Access
*Correspondence:  thomas.vogl@aon.at 
†Thomas Vogl and Mudassar Ahmad contributed equally
2 Queensland University of Technology, 2 George St., Brisbane, QLD 4000, 
Australia
Full list of author information is available at the end of the article
Page 2 of 15Vogl et al. Microb Cell Fact  (2015) 14:103 
yeast, higher eukaryotes) [4]. As there are large numbers 
of affinity, epitope tags and fusion proteins available it is 
challenging to predict the optimal choice for a certain 
POI. Therefore, commonly multiple tags are tested in N- 
or C- terminal positions and screened for optimal results 
[4–7].
However, preparing expression constructs contain-
ing multiple tags may require tedious cloning work. Tags 
are commonly provided on the plasmid adjacent to the 
multiple cloning site (MCS). This requires unique vec-
tors for each tag and N-/C-terminal position. The gene 
of interest (GOI) needs to be cloned into the MCS via 
unique restriction endonuclease (RE) recognition sites. 
These restriction site scars remain in the protein coding 
sequence (CDS) and are later translated into additional 
amino acids, which may interfere with the POI’s proper-
ties. Also cloning strategies based on recombination such 
as Gateway (e.g. [8]) leave the recombination sequence as 
a scar in the CDS.
Ideally, tags should be fused seamlessly to the GOI i.e. 
without any restriction site scars or additional sequences 
from the MCS. Seamless cloning can be achieved by vari-
ous strategies [9]. Frequently, tags are directly added by 
PCR as a 5′ overhang of a primer and thereby seamlessly 
attached to the CDS. This approach requires however a 
unique primer for each tag, N-/C-terminal position and 
each GOI.
We aimed to design a simple, seamless system to facili-
tate testing of multiple tags in N-/C-terminal position at 
minimal cost and effort (e.g. without the need to order 
numerous primers).
Several novel cloning methods are completely inde-
pendent of REs and allow simple assembly of multiple 
fragments solely by short overlaps (around 25  bp) rely-
ing on in  vitro ‘recombination’ (e.g. annealing of single 
stranded overhangs and enzymatic linkage). These meth-
ods include SLIC (sequence and ligation–independent 
cloning) [10], SLiCE (Seamless Ligation Cloning Extract) 
[11], Gibson assembly [12], CPEC (Circular Polymer-
ase Extension Cloning) [13] and are concisely compared 
on the website of the Joint BioEnergy Institute (JBEI), 
Emeryville, CA, USA [14, 15]. All these methods may be 
used to seamlessly add a tag to a protein by adding the 
tag sequence to a PCR primer. However, there is an addi-
tional overhang required for in vitro recombination with 
the vector, requiring relatively long primers. Most incon-
veniently a new primer is needed for each tag, each posi-
tion and each POI to be tested.
Therefore we have based our strategy on type IIS REs. 
In contrast to type II REs, which recognize and cut within 
a palindromic sequence, type IIS REs cut outside of a 
non-palindromic recognition sequence [16, 17]. Thereby 
RE site scars can be circumvented making type IIS REs 
prominent tools for seamless cloning [9]. There are vari-
ous type IIS enzymes available that create different types 
of overhangs including up to 4 bp overhangs suitable for 
sticky end cloning (e.g. Eam1104I [18], BsaI [19, 20]), sin-
gle base pair overhangs that can be applied for TA clon-
ing (e.g. XcmI [21, 22], Eam1105I [23, 24], BciVI [25]) or 
blunt end cloning (MlyI/SchI [25, 26]), see Figure 1a.
In this study we have evaluated type IIS REs for blunt 
end and TA cloning and designed a restriction site free 
cloning (RSFC) strategy that enables simple, seam-
less cloning of a PCR product in frame with any desired 
upstream or downstream sequence in a vector. Based on 
this strategy, we have designed a RSFC vector family of 
40 plasmids for the methylotrophic yeast Pichia pastoris, 
a commonly used protein production host for industri-
ally relevant biocatalysts and biopharmaceuticals [27–
29]. The vectors feature different epitope and affinity tags 
(Myc, FLAG, His, Strep) and fusion proteins (eGFP and 
MBP) in N- and C-terminal position that are provided for 
intracellular and secretory expression.
Results and discussion
Restriction site free cloning (RSFC)
Blunt end vs. TA cloning concept
We aimed to design a vector system in which a single 
PCR product of a GOI can be directly fused, sequence 
independently to various N- or C-terminal tags pro-
vided on different plasmids. Thereby only two primers 
are required to test seamless fusions of multiple tags with 
the GOI. This design is achieved by inserting a stuffer 
(placeholder) fragment flanked by two type IIS RE sites 
in opposite orientations in all vectors (Figure 1b–d). The 
CDSs of different N- and/or C-terminal tags or fusion 
proteins are provided upstream/downstream of the 
stuffer fragment. By digestion using the respective type 
IIS RE, the stuffer fragment including the RE sites is cut 
out, resulting in RE site free vector backbones that can be 
directly ligated with the same PCR product (Figure 1b).
Commonly used type IIS RE based cloning strategies 
such as Golden Gate cloning [19, 20] cannot be used for 
this purpose as they rely on type IIS enzymes creating 
short overhangs such as Eam1104I or BsaI (Figure  1a). 
The use of these enzymes requires also RE digestion of 
the PCR product and the overhangs created on the vec-
tors would differ between tags and impede seamless 
fusions.
Direct, sequence independent cloning of PCR prod-
ucts is in this context only possible by using TA clon-
ing or blunt end ligations. These methods are in general 
not directional (with a few exceptions e.g. [25, 26]) and 
require verification of the orientation (e.g. by colony 
PCR, cPCR). TA cloning is based on the property of Taq-
Polymerase to add a single deoxyadenine (dA) nucleotide 
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at the 3′ ends of amplified DNA [21]. These PCR prod-
ucts can be directly cloned using a vector with a single 
3′ deoxythymidine (dT) overhang. TA cloning works 
more efficiently than blunt end cloning [21], however the 
required dA nucleotide complicates seamless fusions to 
tags as it must be universally incorporated in the transi-
tions between tag and vector. In this respect, blunt end 
Figure 1 Detailed outline of the restriction site free cloning (RSFC) strategy. a Recognition sites of various type IIS REs. The cleavage patterns 
are indicated as red lines. b Schematic workflow of restriction site free cloning. After removal of a stuffer fragment using type IIS REs, a single PCR 
product can be ligated into all vectors in a seamless, sequence independent fashion. The strategy is shown for four vectors but can be extended 
to as many as desired. c Design of the MlyI stuffer fragment for blunt end ligations. The MlyI recognition sequence is written in italics, the entire 
cleavage pattern is underlined. Variable bp are denoted as ‘N’. Upstream sequences may include promoters, N-terminal tags and signal sequences, 
downstream sequences may include C-terminal tags and stop codons. d Design of the BmrI stuffer fragment for TA cloning. Same explanation as (c), 
in addition the incorporation of the dA and dT residues for TA cloning via Start- and Stop/Tyr-codons are shown (red). By varying the last nucleotide 
‘X’ of the Stop/Tyr codon, either translation can be terminated or a C-terminal tag linked in frame. A dA-tailed PCR product suitable for ligation is 
also shown.
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ligations, that are completely sequence independent, are 
more favorable.
We designed test vectors based on type IIS REs for 
blunt end and TA cloning to compare their suitability. 
There is only one blunt end type IIS RE available that 
cuts outside of its recognition sequence (MlyI). MlyI 
has also been established for directional blunt end liga-
tions of PCR products using a lacO, lacZ based blue-
white screening in Escherichia coli [25, 26]. There are 
several type IIS REs available, that create a single base 
3′ overhang (e.g. BmrI, BciVI, HphI, see Figure  1a). We 
tested commercially available preparations of these three 
enzymes all of which showed sufficient cleavage efficien-
cies (data not shown). HphI and BciVI have been previ-
ously used for TA cloning [21, 25], yet these restriction 
sites were present more frequently in the vector back-
bones we wanted to use. Therefore we used BmrI.
The basic sequence design of the transitions between 
the vector, the type IIS restriction sites and the stuffer 
fragment are shown in Figure 1c, d. For blunt end clon-
ing using MlyI, the design is completely sequence inde-
pendent (Figure 1c). For TA cloning, 3′ dT residues must 
be provided on the vector backbone and incorporated in 
the transition between vector and GOI. We solved this 
by using the dT nucleotide of the start codon (ATG) and 
the dA nucleotide of a partial stop codon (TAX), creating 
a 3′ dT base on the reverse strand (Figure 1d). Depend-
ing on the desired sequence context, ‘X’ may be provided 
on the vector side as A/G for a stop codon (translation 
termination) or T/C (coding for tyrosine, for linkage of 
C-terminal tags).
Cloning efficiencies
We compared the basic blunt end and TA cloning based 
system at first with expression vectors for Schizosaccha-
romyces pombe as these plasmids required fewer modi-
fications in the vector backbones than the P. pastoris 
plasmids we intended to use. See Additional file  1: Fig-
ure S1 for plasmid maps and the “Materials and meth-
ods” section for details on the design. After cutting out 
the stuffer fragment using MlyI or BmrI, the vector back-
bones were dephosphorylated to counter act self-ligation. 
Primers for insert amplification were phosphorylated 
prior to ligation (see “Materials and methods” section for 
experimental details and a simple, cost effective proto-
col). Both cloning strategies resulted in similar transfor-
mation efficiencies (via electroporation), approximately 
102–103 colony forming units (cfu)/µg DNA (in the liga-
tion reaction) with self-made competent cells (compe-
tence with circular, supercoiled plasmids: 106–107 cfu/
µg DNA) and in both cases all 10 out of 10 clones tested 
contained an insert. We verified the orientation by cPCR; 
as statistically expected approximately half the clones 
contained an insert in the correct orientation (blunt 
end/MlyI: 5 of 10, TA cloning/BmrI: 7 of 10). Additional 
file  2: Figure S2 outlines a simple cPCR strategy to test 
the correct orientation (using sequencing primers of the 
vector and the primers used for amplifying the insert). 
The vector/insert transitions were confirmed by sequenc-
ing and did not show any mutations. However, when 
cloning an insert into a larger set of vectors using blunt 
end ligations (see P. pastoris vectors below) we noticed 
occasionally single bp deletions of the insert adjacent to 
the vector transition (<5% of constructs). Sequencing of 
additional transformants resulted in all cases in correct 
sequences. Notably, the deletions were always in the 5′ 
ends of the insert and occurred more often after repeated 
freeze/thaw cycles of the PCR product. We therefore rec-
ommend aliquoting the PCR product and vector back-
bones and using them only once.
In general these RSFC ligations resulted in lower effi-
ciencies (cfu/µg DNA) than comparable sticky end 
ligations, but still yielded sufficient numbers of trans-
formants for our standard cloning applications. MlyI 
based blunt end ligations worked similarly efficient as 
BmrI based TA cloning. Previously, TA cloning has been 
reported to be more efficient than blunt end cloning 
[21], however the difference may arise from the different 
enzymes used for vector preparation in our study.
We mutated MlyI sites present in the vector backbones 
to enable the stuffer removal (see “Materials and meth-
ods” section for details). All mutations but one resulted 
in no differences in DNA yields compared to the parental 
plasmids. Mutating a MlyI site in the E. coli pUC origin 
of replication to a sequence previously reported [25, 26] 
decreased plasmid yields to approximately 30% of the 
unmutated parental plasmid (wildtype pUC: ~400 ng/µl, 
MlyI mutated pUC: ~120  ng/µl). The MlyI site appears 
also in other high copy number origins of replication 
(ori) and switching to a lower copy number ori would 
also result in lower plasmid yields. We intended to use 
the RSFC plasmids only for sub cloning and aimed to 
perform expression in P. pastoris. To this end mini prep 
yields (typically >5 µg) were sufficient. However if simi-
lar plasmids should be used for expression in E. coli, we 
would recommend to screen other possible mutations 
of the MlyI site using degenerate primers to restore wild 
type plasmid yields.
However, the blunt end/MlyI based strategy allowed 
completely seamless cloning whereas seamless TA clon-
ing was hindered by the requirement for dT/dA bases 
in the insert/vector transition. This problem is similar 
to the use of typeIIS enzymes creating longer sticky end 
overhangs that need to be complementary between all 
plasmids of a vector family (for example in plasmids by 
BioGrammatics, Inc., Carlsbad, CA, USA and ‘Electra’ 
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plasmids by DNA2.0, Inc., Menlo Park, CA, USA). As 
outlined in Figure 1d, the TA strategy can be still used for 
fusion of the same PCR product to different tags, how-
ever N-terminal tags are always linked via an ATG (cod-
ing for methionine/start), whereas C-terminal tags must 
be linked via tyrosine codons. Tyrosine is naturally a rela-
tively rarely occurring and bulky amino acid, making it 
structurally rather unfavorable as a linker to an adjacent 
tag. In ‘Electra’ plasmids by DNA2.0 this issue is solved 
by adding an additional C-terminal ‘linker’ amino acid 
to all vectors, whereas in the RSFC strategy only vectors 
with C-terminal tags require a linker amino acid. Still we 
have solely focused on the blunt end/MlyI based strategy 
in the following plasmid design for P. pastoris. The blunt 
end/MlyI based ligations required no A-tailing step of 
PCR products but reached similar ligation efficiencies as 
TA cloning and allowed completely sequence independ-
ent fusions.
In summary, our cloning approach, relying on blunt 
end or TA ligations between a phosphorylated PCR prod-
uct and a dephosphorylated vector backbone created by 
type IIS RE digestion, allowed seamless, sequence inde-
pendent cloning at reasonable efficiencies. PCR prod-
ucts can be directly used for ligations and do not need 
RE digestion, therefore any insert sequence can be used 
(TA cloning with proof reading polymerases requires 
a separate dA-tailing step). There have previously been 
type IIS based cloning efforts using blunt end and TA 
ligations for the cloning of PCR fragments [21–26]. How-
ever, these strategies did not allow seamless fusions and 
are in part with lacO, lacZ based blue white screening 
[25, 26], despite the convenience of directional cloning, 
even incompatible with seamless fusions. To distinguish 
our approach from these efforts and other type IIS based 
strategies such as Golden Gate cloning [19, 20], we have 
termed our approach restriction site free cloning (RSFC).
RSFC plasmids for P. pastoris as toolbox for optimizing 
protein production
Tags and fusion proteins
We applied the RSFC cloning strategy to design a plas-
mid family for P. pastoris allowing seamless fusions of 
a GOI with various tags and fusion proteins in N- and 
C-terminal position. There are different expression plas-
mids available for P. pastoris based on various cloning 
strategies such as Gateway [8], TA cloning [22, 25], sticky 
end type IIS ligations (plasmids by BioGrammatics, ‘Elec-
tra’ plasmids by DNA2.0) and ‘classical’ typeII RE/ligation 
based systems ([30–32] and P. pastoris plasmids by Life 
Technologies, Carlsbad, CA, USA). The pCri vector fam-
ily [32] is a multi-host platform, allowing to clone a sin-
gle PCR product via restriction digestion and a MCS into 
different vectors. For P. pastoris only three pCri plasmids 
with a His tag are available. Therefore none of the vector 
systems currently available for P. pastoris offer different 
tags and only the BioGrammatics and Electra plasmids by 
DNA2.0 vectors allow seamless, yet sequence dependent 
cloning still requiring restriction digestion of the insert.
We designed a set of 40 RSFC plasmids for P. pastoris 
(termed pPpRSFC) offering different tags (Myc, FLAG, 
His, Strep) and fusion proteins (enhanced green fluores-
cent protein, eGFP and maltose binding protein, MBP) 
in N- and C-terminal position, see Table  1 for exact 
properties and Figure 2 for a schematic vector map. We 
have assigned numbers (#1 to #40) to the plasmids and 
are using them hereafter when referring to a specific 
construct.
After stuffer removal by MlyI digestion, a single PCR 
product can be cloned in a seamless and sequence inde-
pendent fashion into all vectors, fused to tags and fusion 
proteins ranging from 18 to 1,101 bp in length. Epitope 
and affinity tags are included and constructs with affin-
ity tags contain a TEV protease cleavage site to allow tag 
removal. The hexameric His tag is provided with and 
without TEV protease cleavage site. MBP is provided as 
a fusion protein with the potential to improve solubility 
and act as a purification tag, although in P. pastoris prob-
lems with proteolytic degradation have been reported 
[33]. eGFP is an enhanced version of GFP allowing simple 
fluorescence detection of tagged proteins.
When cloning a GOI into the pPpRSFC vectors, the 
forward primer must be designed starting at the DNA 
sequence coding for the 2nd amino acid of the POI 
(omitting the ATG start codon). The reverse primer must 
be designed starting (on the reverse strand) at the DNA 
sequence coding for the last amino acid/penultimate 
codon (omitting the stop codon). Especially a stop codon 
on the PCR product would interfere with tag fusions, 
therefore the start and stop codon are always provided on 
the vectors and must be omitted from PCR inserts.
P. pastoris is not only suitable for intracellular expres-
sion but can also produce secreted heterologous proteins 
at high titers while secreting only little endogenous pro-
tein [27–29]. Therefore we designed all plasmids also for 
secretory expression using the S. cerevisiae mating fac-
tor alpha pre-pro signal sequence (MF alpha), the most 
commonly applied signal sequence in P. pastoris. The MF 
alpha sequence is processed by two proteases (Ste13 and 
Kex2) that cleave the amino acid sequence KREAEA at 
the end of MF alpha [34]. Kex2 cleaves efficiently after 
KR whereas the Ste13 cleavage after the EA repeat may 
be incomplete, depending on the following amino acids 
of the POI. In several cases removal of the EAEA repeats 
has led to a more homogenous product [35, 36]. There-
fore we designed the basic MF alpha pPpRSFC plasmids 
(#2, 3, 5, 6, 36, 37, 39, 40) with and without the EAEA 
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Table 1 RSFC vector family designed for P. pastoris
# Name Tag/Fusion  
protein, positiona 
and lengthb
TEV protease 
cleavage site
Mode of  
expression
EAEA 
repeat
Selection 
markerc
Plasmid 
size (bp)
1 PPpRSFC – – – NA Intracellular NA Zeocin 4,840
2 pPpRSFC-MFalpha – – – NA Secretory Yes Zeocin 5,104
3 pPpRSFC-MFalpha-noEAEA – – – NA Secretory No Zeocin 5,092
4 pPpRSFC-pGAP – – – NA Intracellular NA Zeocin 3,771
5 pPpRSFC-pGAP-MFalpha – – – NA Secretory Yes Zeocin 4,035
6 pPpRSFC-pGAP-MFalpha-noEAEA – – – NA Secretory No Zeocin 4,023
7 pPpRSFC-N-eGFP eGFP N 240 No Intracellular NA Zeocin 5,584
8 pPpRSFC-C-eGFP eGFP C 239 No Intracellular NA Zeocin 5,584
9 pPpRSFC-MFalpha-N-eGFP eGFP N 239 No Secretory Yes Zeocin 5,848
10 pPpRSFC-MFalpha-C-eGFP eGFP C 239 No Secretory Yes Zeocin 5,848
11 pPpRSFC-N-Myc MYC N 11 No Intracellular NA Zeocin 4,870
12 pPpRSFC-C-Myc MYC C 10 No Intracellular NA Zeocin 4,870
13 pPpRSFC-MFalpha-N-Myc MYC N 10 No Secretory Yes Zeocin 5,134
14 pPpRSFC-MFalpha-C-Myc MYC C 10 No Secretory Yes Zeocin 5,134
15 pPpRSFC-N-FLAG FLAG N 9 No Intracellular NA Zeocin 4,864
16 pPpRSFC-C-FLAG FLAG C 8 No Intracellular NA Zeocin 4,864
17 pPpRSFC-MFalpha-N-FLAG FLAG N 8 No Secretory Yes Zeocin 5,128
18 pPpRSFC-MFalpha-C-FLAG FLAG C 8 No Secretory Yes Zeocin 5,128
19 pPpRSFC-N-His-ncs His N 7 No Intracellular NA Zeocin 4,858
20 pPpRSFC-C-His-ncs His C 6 No Intracellular NA Zeocin 4,858
21 pPpRSFC-MFalpha-N-His-ncs His N 6 No Secretory Yes Zeocin 5,122
22 pPpRSFC-MFalpha-C-His-ncs His C 6 No Secretory Yes Zeocin 5,122
23 pPpRSFC-N-His His N 7 Yes Intracellular NA Zeocin 4,879
24 pPpRSFC-C-His His C 6 Yes Intracellular NA Zeocin 4,879
25 pPpRSFC-MFalpha-N-His His N 6 Yes Secretory Yes Zeocin 5,143
26 pPpRSFC-MFalpha-C-His His C 6 Yes Secretory Yes Zeocin 5,143
27 pPpRSFC-N-MBP MBP N 367 Yes Intracellular NA Zeocin 5,959
28 pPpRSFC-C-MBP MBP C 366 Yes Intracellular NA Zeocin 5,959
29 pPpRSFC-MFalpha-N-MBP MBP N 366 Yes Secretory Yes Zeocin 6,223
30 pPpRSFC-MFalpha-C-MBP MBP C 366 Yes Secretory Yes Zeocin 6,223
31 pPpRSFC-N-Strep Strep N 9 Yes Intracellular NA Zeocin 4,885
32 pPpRSFC-C-Strep Strep C 8 Yes Intracellular NA Zeocin 4,885
33 pPpRSFC-MFalpha-N-Strep Strep N 8 Yes Secretory Yes Zeocin 5,149
34 pPpRSFC-MFalpha-C-Strep Strep C 8 Yes Secretory Yes Zeocin 5,149
35 pPpRSFC-HIS – – – NA Intracellular NA HIS4 7,683
36 pPpRSFC-HIS-MFalpha – – – NA Secretory Yes HIS4 7,947
37 pPpRSFC-HIS-MFalpha-noEAEA – – – NA Secretory No HIS4 7,935
38 pPpRSFC-HIS-pGAP – – – NA Intracellular NA HIS4 6,614
39 pPpRSFC-HIS-pGAP-MFalpha – – – NA Secretory Yes HIS4 6,878
40 pPpRSFC-HIS-pGAP-MFalpha-noEAEA – – – NA Secretory No HIS4 6,866
NA not applicable, ncs no TEV protease cleavage site.
a N- or C- terminal fusion to the POI.
b Length in amino acids (intracellular N- terminal tags are because of the start codon one aa longer, the TEV protease cleavage site (seven aa) is not included in this 
number).
c Zeocin selection is applicable for E. coli and P. pastoris, HIS4 plasmids are based on ampicillin selection in E. coli and used in combination with a histidine auxotrophic 
(his4) P. pastoris strain.
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sequence. Plasmids bearing tags always contain the 
EAEA repeat (Table 1).
Promoters, integration events and resistance markers
The pPpRSFC plasmids are based on the pPpT4 vector 
family reported by Näätsaari et al. [30] and also used as 
a platform for the P. pastoris Electra vectors by DNA2.0. 
The majority of pPpRSFC plasmids contain the promoter 
of the alcohol oxidase 1 gene (pAOX1). This strong, 
tightly regulated methanol inducible promoter is most 
commonly used in P. pastoris [37]. We have also designed 
basic plasmids bearing the glyceraldehyde-3-phosphate 
dehydrogenase promoter (pGAP) to enable methanol 
free, constitutive expression (see Table 1).
In contrast to the yeast S. cerevisiae, where stable, 
autonomously replicating plasmids are available, circular 
plasmids bearing a yeast ARS (autonomously replicat-
ing sequence) are not stable in P. pastoris and genomic 
integration of plasmid cassettes is the method of choice 
for heterologous gene expression [27, 38]. Most com-
monly P. pastoris integration cassettes are created by 
linearizing plasmids or generation of linear cassettes by 
PCR [39, 40] and targeted to the AOX1 locus via homolo-
gous sequences. Depending on the linearization site in 
the plasmid, different homologous recombination events 
can be targeted [38]. The pPpRSFC plasmids allow line-
arization to target gene replacement at the AOX1 locus. 
Thereby the endogenous AOX1 gene is deleted and the 
minor AOX2 gene must take over the function of oxidiz-
ing methanol to formaldehyde. Due to the lower expres-
sion levels of AOX2, these aox1 knockout strains show 
a MutS (methanol utilization slow) phenotype, which 
may result in higher yields than a Mut+ phenotype [41, 
42]. This can be achieved by linearization using BglII. 
If the BglII site is present in the insert, the vectors can 
still be linearized using the rare 8 bp SwaI sites as a fail-
safe backup. If a Mut+ phenotype is desired, the vec-
tors can be linearized using unique REs cleaving in the 
5′ or 3′ homologous sequence (e.g. PmeI, AseI or EcoNI, 
BsrBI). However, due to low homologous recombina-
tion frequencies in P. pastoris wildtype strains [30], even 
when targeting a gene replacement at the AOX1 locus 
(expected MutS phenotype), still the majority of transfor-
mants are Mut+. Therefore it is necessary to validate the 
Mut phenotype by growth on methanol plates.
The RSFC plasmids are based on a modular design, the 
promoter, N- or C-terminal tags, terminator, the resist-
ance marker and the 3′ homologous sequence can be 
easily exchanged using unique restriction enzyme sites 
(Figure 2). Most plasmids are based on Zeocin selection, 
however basic expression plasmids (#35–40) were also 
constructed with a histidine marker to be used with aux-
otrophic strains. The tagged expression cassettes from 
the Zeocin plasmids can be easily shuffled to the histidine 
plasmid backbones using unique PciI and BamHI sites.
In the pPpRSFC plamids not only the transition 
between the insert and the vector is seamless, also the 
transition of the promoter to the start codon and the stop 
codon to the terminator are seamless. In standard RE 
based cloning, the MCS may interfere with translation 
initiation [43] and this appears relevant for the AOX1 
promoter as extensions of the 5′ UTR (also caused by a 
MCS) were shown to negatively affect expression [44].
Applications of RSFC vectors to optimize HRP expression 
in P. pastoris
Effects of tags and fusions proteins in N‑ and C‑terminal 
position
With the set of pPpRSFC plasmids available, we aimed to 
validate the system with a typical application. We tested 
expression of horseradish peroxidase (HRP), a com-
monly used reporter enzyme for signal amplification in 
diagnostic kits and immunohistochemistry. Secretory 
expression of HRP has been previously demonstrated in 
P. pastoris [42, 45–47]. Cytoplasmic expression promised 
little chance of success as HRP is a secretory plant per-
oxidase that requires formation of disulfide bridges and 
is typically glycosylated in the secretory pathway [48, 49]. 
Still, we tested the basic pPpRSFC plasmid (#1, untagged, 
pAOX1) for cytoplasmic HRP expression. This construct 
showed neither activity in the supernatant (Figure 3) nor 
in the cytoplasm (data not shown). Therefore different 
tags were only evaluated for secretory expression. A sin-
gle PCR fragment of HRP was cloned into the vectors as 
outlined above. All pAOX1 plasmids were linearized via 
BglII sites to target a gene replacement event at the AOX1 
locus, and screened for a MutS phenotype, which has 
been reported to be more favorable for HRP expression 
than Mut+ [42].
The different tags and positions had diverse effects on 
volumetric HRP activities (Figure 3) and led to valuable 
insights. For all tags, the N-terminal version was giving 
higher activities than the C-terminal version. For the 
larger fusion proteins (eGFP and MBP), C-terminal tag-
ging even led to almost complete loss of activity (#10 and 
#30). Comparing the tagged construct with the highest 
activity (#21) with the construct of the lowest activity 
(#10) gives a 31 fold difference. N-terminal tagging with 
the relatively large eGFP (and MBP) did not strongly 
affect activity, whereas shorter tags (Myc, FLAG, His, 
Strep) showed varying effects. The N-terminally His 
tagged construct with TEV protease cleavage site (#25) 
showed the lowest activity of all N-terminally tagged 
proteins. However, the N-terminal His tagged construct 
without TEV protease cleavage site (#21) showed activ-
ity similar to other tags, hinting a negative effect of the 
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TEV protease cleavage site in this context. Changes of 
the MFalpha sequence by removal of the EAEA sequence 
decreased activity 1.6 fold with the methanol inducible 
AOX1 promoter (#2 vs. #3). With the constitutive GAP 
promoter (#5 vs. #6), removal of the EAEA sequence even 
led to a 17 fold decrease in activity. A possible mechanis-
tic explanation would be that the EAEA repeats improved 
secretion due to increased Kex2 cleavage efficiencies [50, 
51]. pGAP driven HRP expression was therefore, depend-
ing on the presence of EAEA repeats, competitive to the 
methanol inducible pAOX1. Due to shorter process times 
(not requiring methanol induction) pGAP driven expres-
sion may even be more favorable for HRP production 
regarding space time yields and process setup.
The effects seen on volumetric activities by using dif-
ferent tags may be caused by various reasons. On the 
one hand the tags may have interfered to a different 
extent with protein folding or access of the substrate to 
the active site thereby negatively affecting activity. On 
the other hand they also may have affected the protein 
yields by altering the protein stability, interfering with the 
secretion process or even on the mRNA level with tran-
script stability. Also the tags or linker sequence may have 
targeted proteolytic degradation, as previously reported 
for MBP in P. pastoris [33]. However, as we aimed only to 
evaluate the suitability of the RSFC strategy for screening 
different tags, we did not further investigate the under-
lying causes. The pPpRSFC plasmid family proved to be 
a simple tool to optimize volumetric activities of tagged 
HRP, showing that especially the tag positions and pres-
ence of EAEA repeats are crucial factors.
Figure 2 Representative map of P. pastoris RSFC plasmids. The features of all RSFC plasmids designed are summarized in this schematic map. Differ-
ent promoters, N/C-terminal tags, resistance markers are shown. pGAP plasmids do not contain the 3′ AOX1 homologous sequence for recombina-
tion (3′ AOX1 HS). HIS4 vectors contain in addition an ampicillin resistance cassette. The mating factor alpha signal sequence (MF alpha) is optional 
and only present in secretory plasmids. See Table 1 for the part combinations created in this study. Features are not drawn to scale. Exact plasmid 
maps are provided in the Additional file 3 in GenBank format.
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Fluorescence microscopy of strains expressing eGFP tagged 
HRP
GFP has routinely been used in P. pastoris as an intra-
cellular reporter for comparing promoter activities [52–
54] and to facilitate screening of protein production by 
testing fusions proteins [55], especially for membrane 
proteins [56–58]. Concerning GFP fusions of secretory 
proteins, conflicting results were obtained. In some cases 
GFP was successfully used as secretion reporter and for 
protein fusions [59–62]. In other cases problems with 
secretion (e.g. intracellular retention) were noticed [63–
66]. As we had also designed N- and C-terminal fusions 
with eGFP (including the MFalpha signal sequence 
for secretion, #9 and #10), we performed fluorescence 
microscopy to investigate possible cellular retention and 
bottlenecks in the HRP secretion process.
The N-terminal eGFP-HRP fusion exhibited largely 
unchanged HRP activity, whereas the C-terminally 
tagged version had almost completely lost activity (Fig-
ure  3). We also included controls of intracellular eGFP 
expression (#1) and secretory eGFP alone (without an 
HRP fusion, created by self-ligating #9). Fluorescence 
microscopy images of methanol grown cells are shown in 
(Figure 4). While cytoplasmic expression showed bright 
fluorescence of the whole cell (Figure  4d), all secretory 
constructs (Figure  4a–c) showed punctate structures. 
These structures appeared somewhat similar to ER or 
Golgi mistargeting observed previously when expressing 
a GFP tagged membrane protein (human µ-opioid recep-
tor, a G-protein coupled receptor) [65]. Most notably 
also the control of eGFP alone (Figure  4c), without an 
HRP fusion showed this retention. eGFP was appar-
ently poorly secreted in P. pastoris and effects evoked by 
HRP may be masked and outweighed by the poor eGFP 
secretion.
We also measured eGFP fluorescence in the superna-
tant and the cell fraction (Additional file  4: Figure S3). 
Fluorescence in the supernatant could be detected for 
secretory constructs (Additional file  4: Figure S3a–c), 
while the cytoplasmic eGFP expression control (Addi-
tional file  4: Figure S3d) showed only marginal fluores-
cence in the supernatant. However, also for the secretory 
constructs (Additional file  4: Figure S3a–c) intracellular 
fluorescence surpassed fluorescence in the supernatant 
approximately 5- to 12-fold. These results suggested 
together with the microscopy images, that large amounts 
of eGFP were withheld in the secretion process. In this 
respect, eGFP fusion proteins may be used with caution 
when investigating secretory processes in P. pastoris. 
However, these effects may also be protein dependent, 
as there were cases reported where GFP was successfully 
used to evaluate signal sequences [59, 60] and some GFP 
fusion proteins were sufficiently secreted [61, 62].
Conclusions and outlook
The RSFC cloning strategy outlined here and the 
pPpRSFC plasmid family are simple tools to optimize 
expression of tagged proteins with little cloning efforts. 
RSFC requires at first the design and assembly of the vec-
tor family to be used. However, subsequent screening is 
Figure 3 Type of tag and position (N/C-terminal) strongly affect volumetric HRP activities. Volumetric HRP activities in the supernatant with ABTS as 
substrate after cultivation on methanol for 72 h are shown. The pPpRSFC plasmids used are indicated via the numbers given in Table 1, the use of a 
signal sequence (MFalpha), different promoter than pAOX1 and if applicable tag and position (N/C) are given. Mean values and standard deviations 
of biological triplicates are shown.
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drastically facilitated as large amounts of vector back-
bones can be prepared at once by MlyI digestion. Subse-
quently, the backbones ready for cloning can be frozen as 
aliquots and thawed when needed.
There have been systems reported previously that allow 
testing of the expression of a POI in different expres-
sion hosts by using only two PCR products [67]. This 
approach is based on ligation-independent cloning (LIC) 
similar to [10–13, 68]. While these methods allow highly 
efficient, seamless cloning, they rely on the annealing of 
single stranded overhangs, thereby requiring identical 
sequences between vector and insert. Therefore these 
methods are not suitable for seamless, sequence inde-
pendent fusions possible with RSFC. However, as a down-
side of RSFC the blunt end ligations work less efficiently 
than annealing based in  vitro recombination methods 
[10–13] and confirmation of the correct orientation is 
required. Otherwise only about 50% of the transformants 
show the desired orientation which is a disadvantage for 
library approaches. Nevertheless, after stuffer removal, 
inserts can also be cloned directionally into RSFC plas-
mids by in vitro recombination methods (such as Gibson 
assembly [12]). However this task requires the design of 
a separate primer for every tag and position to be tested 
as the overhang required for annealing changes between 
the vectors. We recommend using in vitro recombination 
methods with pPpRSFC plasmids when testing only a few 
constructs. When testing a larger number of constructs, 
the increased costs for primers and materials associated 
with in vitro recombination methods outweigh the costs 
for cPCRs to test the orientation of blunt end ligations. 
When performing a single experiment and cloning a low 
number of GOIs with only one tag, it will be more effort 
to set up a RSFC vector than to order a few long primers. 
However, if routinely a large number of GOIs should be 
screened with a set of tags in different positions, RSFC 
vectors are a powerful strategy.
A limitation of the RSFC system reported here is the 
use of MlyI, the only type IIS enzyme performing a blunt 
end cleavage. The recognition sequence of MlyI is five bp 
long (Figure 1a), thereby posing a problem as it appears 
statistically once per 512 bp (45/2) [69]. This may require 
frequent removal of MlyI sites in the vector backbones 
to be used. MlyI sites in CDSs of tags, fusion proteins 
and resistance markers can be easily removed by mutat-
ing the MlyI sequence to synonymous codons. However, 
mutating sites present in promoters, terminators or ori-
gins of replication have to be validated for unchanged 
functionality (or must be exchanged for parts free of 
MlyI sites). These issues could be solved by using artifi-
cial type IIS REs with longer recognition sequences. The 
catalytic domain of the archetypical type IIS enzyme FokI 
has been fused to I-SceI, a homing endonuclease with an 
18  bp recognition sequence. This chimeric meganucle-
ase showed sufficient cleavage resulting in 4  bp ‘sticky’ 
overhangs that could be ligated at 90% fidelity [69]. Fol-
lowing this strategy, the catalytic domain of MlyI (which 
is similar to FokI [70]) could also be fused to I-SceI. Sta-
tistically an 18  bp recognition sequence would appear 
approximately once in 1011 (418) bp, however I-SceI rec-
ognizes also slightly degenerate sequences leading to an 
estimated appearance once in 108 bp [69, 71, 72], which 
Figure 4 Fluorescence microscopy of fusions of HRP to GFP. Bright field images are shown on top, fluorescence images below. a HRP N-terminally 
tagged with eGFP (#9-MFalpha-N-eGFP-HRP), b HRP C-terminally tagged with eGFP (#10-MFalpha-C-eGFP-HRP), c control of eGFP with MFalpha 
(self-ligated #9), d control of cytoplasmic eGFP expression (#1-eGFP), e negative control of empty MutS strain. For the bright field image of panel (c) 
brightness was decreased −11%, contrast was increased +44% for better comparability with the other panels.
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would still surpass the specificity of wildtype MlyI by sev-
eral orders of magnitude.
Most vectors for P. pastoris have been conceptualized 
solely as straightforward expression vectors ([8, 22, 25, 
30, 31] and P. pastoris plasmids by Life Technologies, 
BioGrammatics and DNA2.0) and few plasmid families 
allow to fine-tune expression [30, 31]. The 40 plasmids 
reported here extend the scope of applications and facili-
tate characterization and optimization of the production 
of heterologous proteins in P. pastoris. The RSFC strategy 
outlined here is not limited to tags and fusions proteins, 
but could also be applied to compare different promot-
ers or signal sequences in other expression systems. Simi-
larly, isoenzymes or families of homologous enzymes can 
be fused to tags to screen for better expression, solubil-
ity or other properties to identify enzymes combining 
desired biological, chemical and technological features.
Materials and methods
Chemicals and media
Phusion DNA Polymerase, restriction endonucleases 
and other DNA modifying enzymes were acquired 
from Thermo Fisher Scientific (Waltham, MA, USA) or 
New England Biolabs (Ipswich, MA, USA). Miscellane-
ous chemicals were purchased from Becton, Dickin-
son and Company (Franklin Lakes, NJ, USA), Carl Roth 
(Karlsruhe, Germany) and Fresenius Kabi Austria (Graz, 
Austria).
Plasmids were isolated using a GeneJET Plasmid 
Miniprep Kit by Thermo Fisher Scientific. The standard 
protocol was optimized for MlyI based constructs to 
compensate the decreased plasmid yields. A single colony 
of a strain bearing the respective plasmid was streaked on 
an agar plate containing the respective antibiotic. After 
incubation overnight, a cell pellet (approximately 0.1  g 
wet cells) was scratched of the plate and used for the iso-
lations (final elution volume: 100 µl of ddH2O).
Agarose embedded DNA, restriction digests and PCRs 
were purified using a Wizard SV Gel and PCR Clean-Up 
System by Promega.
P. pastoris strains were grown on full medium (yeast 
extract, peptone, 2% glucose, YPD), buffered minimal 
dextrose (BMD) and buffered minimal methanol medium 
with 0.5% methanol (BMM) as described by Weis et  al. 
[16]. As only exception we used 2% glucose in the BMD 
medium and for HRP expression, media were supple-
mented with 1  mmol/l ferrous sulfate heptahydrate 
(FeSO4.7H2O). Escherichia coli strains were selected on 
LB-medium containing 25  μg/ml Zeocin™ (Life Tech-
nologies, Carlsbad, CA, USA). P. pastoris transformants 
were selected on YPD agar plates containing 100  μg/
ml Zeocin. Primers were ordered from Integrated DNA 
Technologies (Leuven, Belgium), see Additional file  5: 
Table S1 for the sequences.
Plasmid construction
pombe RSFC test vectors pGAZ2‑TA‑BmrI‑stuffer 
and pGAZ2‑Blunt‑MlyI‑stuffer
For all cloning work an E. coli Top10 F’ strain was 
used. The vectors for initially comparing blunt end 
and TA cloning were based on a replicative S. pombe 
vector pGAZ2 (Additional file  1: Figure S1, unpub-
lished results). For the TA-cloning vector ‘pGAZ2-TA-
BmrI-stuffer‘, a stuffer fragment was amplified using 
primers TA_fwd_HindIII+BmrI+stuffer and TA_rev_
BamHI+BmrI+stuffer (see Additional file  5: Table S1) 
and cloned into pGAZ2 via HindIII and BamHI sites. The 
stuffer fragment was selected as a sequence that has no 
significant homology to E. coli and S. pombe genomes 
and lacks MlyI, BmrI, HindIII and BamHI RE sites; we 
used a part of a P. pastoris alpha, alpha trehalase gene. 
The ‘pGAZ2-Blunt-MlyI-stuffer’ vector required mutat-
ing two MlyI sites in the vector backbone. This was done 
by PCR amplifying the vector using primers pUC_mut_
MlyI_fwd  +  pUC_mut_MlyI_rev and ZeoCDS_mut_
MlyI_fwd  +  ZeoCDS_mut_MlyI_rev using Pfu Ultra 
polymerase (Agilent Technologies, Santa Clara, CA) 
followed by DpnI digestion to remove template vector. 
The MlyI site in the pUC was mutated to the sequence 
reported by Rao et  al. [25], the MlyI site in the zeocin 
resistance gene was mutated to a synonymous codon. 
After transformation, introduction of the correct muta-
tions were confirmed by Sanger sequencing. Both plas-
mids do not provide seamless fusions, as the stuffer 
fragments were for convenience inserted via HindIII and 
BamHI sites leaving RE site scars. For test purposes the 
gene coding for Thermomyces lanuginosus endo-beta-
1,4-D-xylanase was amplified using primers Xyla_fwd 
and Xyla_rev and cloned into the two vectors (detailed 
protocol see below).
P. pastoris pPpRSFC plasmid family
The expression plasmids used in this study are based 
on the pPpT4 P. pastoris/E. coli shuttle vector family 
(e.g. GenBank accession number JQ519690.1) reported 
by Näätsaari et  al. [30]. Two MlyI sites in the backbone 
(pUC and zeocin resticane gene) were mutated in the 
same way as in the S. pombe plasmids of this study (Addi-
tional file  1: Figure S1; same primers as in Additional 
file 5: Table S1) and confirmed by sequencing. The AOX1 
promoter, MlyI stuffer fragment and AOX1 terminator 
were amplified in separate PCR reactions using primers 
PAOX1_PciIF/OePAox1StufferR, OestufferF/OeStufferR 
and OeAox1TTstufferF/Aox1TT_BamHIR respectively. 
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In the subsequent overlap extension PCR reactions 
the fragments were joined together using primer pair 
PAOX1_PciIF/AOX1TT_BamHIR followed by restric-
tion with PciI/BamHI and were cloned in a vector back-
bone with mutated MlyI sites to create an intermediatory 
plasmid backbone termed ‘pPp’. The stuffer fragment 
sequence was selected from as a sequence that has no 
homology to E. coli and P. pastoris and lacks unique RE 
used in the pPpRSFC plasmid family. We selected a part 
of a gene involved in the S. cerevisiae biotin metabolism. 
An EcoRI site in the stuffer was mutated using primers 
pairs OeEcoRIF and OeEcoRIR. There appeared a few 
additional mutations in the stuffer that had no functional 
consequences and where therefore left unchanged (see 
plasmid sequences in Additional file 3).
For constitutive plasmids, the GAP promoter was 
amplified via primers GAP_PciIF/OeGapStuffR and 
was cloned into the pPp backbone using PciI/EcoRI 
to create #4 (pPpRSFC-pGAP). The 3′ AOX1 homolo-
gous sequence was amplified via primers 3′AOX1_
PstIASCIF/3′AOX1_KpnISwaIR and was cloned into pPp 
using KpnI/PstI restriction sites to create #1 (pPpRSFC). 
For secretory expression plasmids, the MFAlpha 
sequence was amplified using primer pair AlphaFSSF/
AlphaEcoRIR (or aEAEAEcoRIR for insertion of Glu-Ala 
repeats). The AOX1/GAP promoters were amplified via 
primers PAOX1_PciIF  +  OeAlphaPAox1R/GAP_PciIF+ 
OeGapAlphaR. The MFAlpha sequence was fused with 
pAOX1/pGAP using primers PAOX1_PciIF+ AlphaE-
coRIR (expression cassette for #3) or PAOX1_PciIF+ 
aEAEAEcoRIR (expression cassette for #2),/GAP_PciIF+ 
AlphaEcoRIR (expression cassette for #6) or GAP_PciIF+ 
aEAEAEcoRIR (expression cassette for #5). The pAOX1-
MFAlpha PCR products were cloned into pPpRFSC via 
PciI/EcoRI sites to create #3 and #2. The pGap-MFAlpha 
fusion construct was cloned into pPpRSFC-pGAP via 
PciI/EcoRI restriction site to construct pPpRSFC-#6 and 
#5.
pGAP plasmids do not contain the 3′ AOX1 sequence 
for homologous integration in the AOX1 locus. Plasmids 
#1 to #6 were made initially and completely sequenced. 
In the creation of the following plasmids, only newly 
inserted parts (and the RE sites used for cloning) were 
confirmed by sequencing. A full description of how the 
28 plasmids (#7–#40) with the N- and C- terminal tags 
were created would be beyond the scope of this section 
and is provided in the Additional file 5: Table S1 (spread-
sheets on plasmid construction). For further details 
consult the annotated plasmid sequences provided in 
Additional file 3.
The HRP gene (isoenzyme A2A [46, 47]) was 
amplified using primers HRP-A2-RSFC-fwd and 
HRP-A2-RSFC-rev and cloned in the respective vectors 
(detailed protocol see below).
RSFC cloning of inserts and colony PCRs
For blunt end cloning, the vector backbone was dephos-
phorylated using either Thermo Scientific shrimp 
alkaline phosphatase or FastAP according to the manu-
facturer’s recommendations. The backbone was gel puri-
fied and used for ligations with phosphorylated PCR 
products. Prior, PCR primers were phosphorylated using 
Thermo Scientific T4 Polynucleotide Kinase according to 
the manufacturer’s recommendations. Subsequently the 
reaction mixtures containing the phosphorylated primers 
were desalted on nitrocellulose filters (Merck Millipore, 
Darmstadt, Germany) and added to the PCR (Phusion 
polymerase). Ligations were performed using the blunt 
end protocol provided for Thermo Scientific T4 DNA 
Ligase.
For TA cloning, phosphorylated Phusion PCR prod-
ucts were purified (Promega Wizard SV Gel and PCR 
Clean-Up System) and dA-tailed using Taq-Polymerase 
(GoTaq Flexi, Promega [Fitchburg, WI, USA], standard 
buffer, 0.2 mmol/l dATP, 30 min incubation at 72°C) and 
directly used for ligation (blunt end protocol provided for 
Thermo Scientific T4 DNA Ligase).
To verify the correct orientation by colony PCR, prim-
ers were selected as outlined in Additional file 2: Figure 
S2. A tiny amount of an E. coli colony from a transfor-
mation of the respective ligation was added to a GoTaq 
Flexi reaction. The manufacturer’s protocol was followed 
except reducing the reaction volume to 20 µl and increas-
ing the initial denaturing step to five min to break the 
cells.
P. pastoris transformations and screening
For testing the pPpRSFC plasmids, the P. pastoris 
CBS7435 wildtype strain was used. Plasmids bearing 
the AOX1 promoter were linearized with BglII, plasmids 
with pGAP were linearized with SwaI. All linearized plas-
mids were transformed into competent P. pastoris cells 
prepared by the condensed protocol reported by Lin-
Cereghino et al. [73]. Only low amounts of DNA (0.5 µg) 
were used for the transformations to avoid multicopy 
integration. A landscape of 80 clones was screened and 
checked for the desired MutS phenotype on minimal 
methanol plates. Ten MutS clones were rescreened for 
uniform expression; a single representative clone was 
used for the subsequent characterizations. Screenings, 
rescreening and characterizations were performed in 
deep well plates as described previously [74]. BMD 2% 
was used instead of BMD 1% (giving higher yields, data 
not shown) and the methanol induction was performed 
in 12 h intervals for 72 h.
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HRP activity assay, eGFP fluorescence microscopy 
and measurements
HRP activity assays with 2,2′-azino-bis(3-ethylbenzthia-
zoline-6-sulphonic acid) diammonium salt (ABTS) were 
performed as described previously [42]. For intracellu-
lar HRP activity measurements, cells were broken using 
Yeast Protein Extraction Reagent (Y-PER from Thermo 
Scientific).
The cell suspensions of eGFP expressing strains were 
centrifuged and washed in an equal amount of water 
before fluorescence microscopy (Leica Microsystems, 
Germany, DM LB2, DFC350FX) at 1,000-fold magnifi-
cation, fluorescence images were taken using filter set 
‘I3’ [excitation filter BP 450–490]. eGFP fluorescence 
(ex/em 488/507  nm) and OD600 were measured in a 
Synergy MX plate reader (Biotek, Winooski, VT, USA) 
using micro titer plates (Nunc MicroWell 96-Well 
Optical-Bottom Plates with Polymer Base, Black; 
Thermo Fisher Scientific). Cell suspensions were 
diluted to be within the linear range. The background 
measurements of diluted medium were subtracted. 
Subsequently the relative fluorescence units were nor-
malized per OD600.
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